Diabetes control even easier, Biocon’s drug got approval

Good News for Diabetes patients: There is a great news for diabetics. The US drug controller has approved Biocon’s diabetes drug.

New Delhi. There is a new good news for diabetes patients. They don’t have to rely solely on insulin if they want to lower their blood sugar. The US Food and Drug Administration has approved the drug Biocon Vytris. This is the first drug that will act like insulin for diabetic patients and help reduce blood sugar.

A diabetes drug approved by the US Food and Drug Administration (USFDA) means you will no longer need insulin. Patients can now use this medicine even without taking a doctor’s prescription. This is a biggest success for us, because diabetes is a growing disease not only in India but in the world. Whose treatment has become easier now.

You no longer have to rely solely on insulin to lower blood sugar levels. You will also be able to use Biocon Vytris. It has been approved by the Food and Drug Administration of America. This is the first such drug, which will act like insulin and will also help in reducing the level of sugar in the blood. This has proved to be the best research for science, because till now there was only one treatment for such a big disease – insulin. This research proves that we are moving forward to deal with this serious disease.

Also read: Low Carb Diet Effective In Diabetes

Biocon will make this biosimilar drug and Semagli will be marketed in the US by Biocon’s partner company Vitris. Janet Woodcock, USFDA acting commissioner, said in a press release that it is especially effective for people who depend on insulin daily. He told that now you can use it. It is an interchangeable biosimilar product which is really very economical.

Biological products are being launched in the market. It is a low cost medicine which is safe, safe, of good quality and effective. Which will prove beneficial for diabetic patients.

Today there are many diabetes patients in the country and the world for whom this medicine will prove beneficial. Everyone is very happy with the arrival of this new drug in the market, because after a long time something new has been seen for the people suffering from diabetes. Which is a good news for us.

Also read: How To Control Sugar

The USFD has stated that the interchangeable biosimilar drug is safe. It will prove beneficial for diabetic patients. The patient who starts using it will not feel much difference.

Also read: Some Home Remedies To Cure Diabetes


Source link